Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs Associated with Therapy interrupted (Page 4)

667 drugs have been associated with Therapy interrupted in FAERS reports.

Drug Reports Deaths Hosp. Life-Threat.
OZANIMOD 52 0 4 1
RITUXIMAB-ABBS 52 4 7 1
TENAPANOR 52 1 24 1
TIOTROPIUM 52 1 14 1
TROFINETIDE 52 0 9 0
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN 51 3 23 1
VIGABATRIN 51 0 21 0
DORNASE ALFA 50 0 42 0
ROSUVASTATIN 50 0 14 1
MIDAZOLAM 49 2 16 0
OCTREOTIDE 49 0 36 0
OMALIZUMAB 49 1 33 1
RIVAROXABAN 49 1 31 4
TRALOKINUMAB-LDRM 49 0 3 0
ALPELISIB 48 0 30 1
FLUTICASONE\SALMETEROL 48 0 18 0
CARBOPLATIN 47 2 33 0
LEVODOPA 47 1 8 0
ADALIMUMAB-ADAZ 46 2 15 0
FINGOLIMOD 46 0 26 0
GABAPENTIN 46 1 19 3
PEXIDARTINIB 46 0 3 0
ESTRADIOL 45 1 12 1
GLECAPREVIR\PIBRENTASVIR 45 0 17 1
CALCIUM\ICODEXTRIN\MAGNESIUM\SODIUM\SODIUM 44 6 21 0
DEVICE 44 1 18 0
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE 44 0 3 0
GLUTAMINE 44 0 18 0
PREGABALIN 44 0 13 0
TOBRAMYCIN 43 0 35 0
CABOZANTINIB S-MALATE 42 3 9 0
CYTARABINE 42 5 40 0
EMPAGLIFLOZIN 42 4 26 4
FUROSEMIDE 42 3 29 4
LACTULOSE 42 7 31 0
SOTATERCEPT-CSRK 42 0 40 0
TAFAMIDIS 42 1 32 0
PANTOPRAZOLE 40 0 8 0
FLUOROURACIL 39 2 22 0
HYDROXYCHLOROQUINE 39 0 19 1
LAMOTRIGINE 39 0 24 1
OCRELIZUMAB 39 0 2 0
VENETOCLAX 39 0 25 0
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM 38 6 18 0
CARIPRAZINE 38 0 5 0
DARATUMUMAB\HYALURONIDASE-FIHJ 38 0 17 0
DEUTETRABENAZINE 38 1 20 1
DOFETILIDE 38 0 30 0
METOPROLOL 38 0 18 3
NIVOLUMAB 38 1 12 0
« 1 2 3 4 5 6 7 … 14 »